YEN-TING LINLiu Y.-N.JIN-YUAN SHIH2020-05-252020-05-2520192234-943Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85073033008&doi=10.3389%2ffonc.2019.00880&partnerID=40&md5=de019a928eb1fa6cc4be71ee77efda81https://scholars.lib.ntu.edu.tw/handle/123456789/494420[SDGs]SDG3The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancerjournal article10.3389/fonc.2019.008802-s2.0-85073033008